The following are some recommended resources to help educate you about glaucoma:
Current GLEAMS Newsletter on the Glaucoma Research Foundation's web site
Children's
Glaucoma Foundation
Glaucoma Service
& Foundation to Prevent Blindness at Wills Eye Hospital
International Glaucoma
Association
New
York Glaucoma Research Institute
The Glaucoma
Foundation (TGF)
| |
| |
|
LUMIGAN (bimatoprost ophthalmic solution) 0.03% is for the treatment of high eye pressure, also called intraocular pressure (IOP), in people with open-angle glaucoma or ocular hypertension.
Important Safety Information
LUMIGAN (bimatoprost ophthalmic solution) 0.03% has been reported to cause darkening (pigmentation) of eye color, eyelid skin and eyelashes, as well as increased growth of eyelashes. Pigmentation changes can increase as long as LUMIGAN is used. After stopping LUMIGAN, darkening of eye color is likely to be permanent while darkening of the eyelid skin and eyelash changes may be reversible. The effects of increased darkening beyond 5 years are not known.
The most common side effects are eye redness, growth of eyelashes, and itchy eyes.
|
|
|